Search

Your search keyword '"Yamada, Taketo"' showing total 220 results

Search Constraints

Start Over You searched for: Author "Yamada, Taketo" Remove constraint Author: "Yamada, Taketo" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
220 results on '"Yamada, Taketo"'

Search Results

2. Toward Better Driving with Gaze Awareness Environment Supported by Area Segmentation

4. Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma

7. Single-cell atlas of colonic CD8+ T cells in ulcerative colitis

10. Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

14. Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies

16. Supplementary Figure 2 from Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer

17. Supplementary Figure 3 from Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer

18. Supplementary Figures 1-2, Tables 1-2 from CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma

19. Supplementary Figure 4 from Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer

21. Supplementary Table 2 from Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer

22. Supplementary Figure 1 from Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of Human Lung Cancer

31. GTN057 , a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c‐MET tyrosine kinase

37. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma

39. IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3–Specific B Cell Receptor Knock-in Mouse

45. Inhibition of immunoglobulin class-switching prevents pemphigus onset in desmoglein 3-specific B cell receptor knock-in mouse

46. Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review

47. Arf1 and Arf6 Synergistically Maintain Survival of T Cells during Activation

49. Serum soluble CD26/DPP4 titer variation is a potential prognostic biomarker in cancer therapy with a humanized anti-CD26 antibody

Catalog

Books, media, physical & digital resources